Cardioxyl Pharmaceuticals Receives $28,050,000 Series B Financing Round

  • Feed Type
  • Date
    11/7/2012
  • Company Name
    Cardioxyl Pharmaceuticals
  • Mailing Address
    Exchange East 1450 Raleigh Road Chapel Hill, NC 27517 USA
  • Company Description
    Cardioxyl Pharmaceuticals’ mission is the discovery and development of newclasses of safe and effective therapeutic agents for the treatment ofcardiovascular disease. Cardioxyl’s initial program is a novel medication forthe treatment of acute decompensated heart failure.
  • Website
    http://www.cardioxyl.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $28,050,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    Proceeds from this latest round will be used to further advance Cardioxyl’s second-generation nitroxyl (HNO) donor programs for the treatment of acute and chronic heart failure.
  • M&A Terms
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor

Trending on Xconomy